Interview with Rajiv Chopra, President DSM India & MD DSM Nutirtional…
With almost EUR 9bn turnover and more than 22,000 people worldwide, Royal DSM has truly grown into an MNC. Within the global market, there is no doubt that India has…
Address: Windsor House, 401, Fourth Floor, | CST Road, Kalina | Mumbai 400098, India
Tel: + 91 22 4034 9100 / 101
Web: http://www.dsm.com/en_US/cworld/public/home/pages/home.jsp
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting
its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity,
environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global markets such as food and
dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical
and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver
annual net sales of around € 9 billion. The company is listed on NYSE Euronext. More information can be
found at www.dsm.com.
DSM Nutritional Products is the world’s leading supplier of vitamins and carotenoids to the feed, food, pharmaceutical and cosmetic industries.
With almost EUR 9bn turnover and more than 22,000 people worldwide, Royal DSM has truly grown into an MNC. Within the global market, there is no doubt that India has…
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and active pharmaceutical ingredients for the last month. With restrictions beginning to ease up, some manufacturing…
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic pharmaceuticals market. Now accounting for over 90 percent of all prescriptions dispensed in…
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions for Indian pharma manufacturers and could lead to global shortages. Shortages and Price…
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the coronavirus, to regulatory reform, the spike in USFDA warning letters…
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with a new manufacturing facility and an expansion into the Australia…
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the country’s pharmaceutical turnover and 28 percent of its pharmaceutical exports. Given the…
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the life sciences industry as head of Piramal Pharma Solutions (PPS) in…
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports to developed nations, are increasingly forging closer links. With US trade tariffs affecting both…
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s ambitious healthcare insurance scheme, “Modicare” and delves into some of its critical challenges and associated…
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more empowered regulator in India if the country is to build public confidence in its pharma output…
Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe, hence the reason India has been dubbed ‘ the pharmacy to the world.’ Furthermore,…
Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming years, Indian companies have – in the meantime – been rapidly…
See our Cookie Privacy Policy Here
